Many Stroke Patients on 'Clot-Busting' tPA May Not Need Long Stays in the ICU
Johns Hopkins MedicineA Johns Hopkins study of patients with ischemic stroke suggests that many of those who receive prompt hospital treatment with "clot-busting" tissue plasminogen activator (tPA) therapy can avoid lengthy, restrictive monitoring in an intensive care unit (ICU).